We investigated whether injections of activated cytokine-induced killer ( CIK ) cells ( CD@ + / CD@ + and CD@ + / CD@ - T cells and CD@ - / CD@ + natural killer cells ) prolongs recurrence-free survival of patients after curative therapy for HCC .